Who we are
In 2016 Prof. A. Bechthold from the University of Freiburg and Prof H. Pfundner from Roche created the idea of a new specialty line “Drug Development & Regulatory Affairs” within the existing Master’s degree program in pharmaceutical sciences. There is a need in the industry for university graduates with sound knowledge in the areas of pharmaceutical drug development and regulatory affairs. These topics are usually underrepresented in existing pharmacy degree programs.
Vision and Goals
By connecting pharmacy students with the Pharmaceutical industry and academic partners our organization facilitates a network between these parties. In a global world the pharmacy student of today wants to be involved and connected to potential employers as early as possible. He/she wants to gain experience and insights to the pharmaceutical industry.
The research group is thus awarded for its outstanding work and publication “Secondary nucleotide messenger c-di-GMP exerts a global control on natural product biosynthesis in streptomycetes” in the journal “Nucleic Acid Research“, carried out by Dr. Roman Makitrynskyy, Olga Tsypik, Desirée Nuzzo of the working group in cooperation with Dr. Thomas Paululat, head of NMR facilities and research associate at the University of Siegen, and Prof. Dr. David L. Zechel, Department of Chemistry, Queen’s University, Kingston, Ontario, Canada under the direction of Prof. Dr. Andreas Bechthold.
At the winter semester 2021/22, there will be another opportunity to enroll in the still relatively young and unique Master’s program “Regulatory Affairs & Drug Development” at the Institute of Pharmaceutical Sciences of the Albert-Ludwigs-University of Freiburg. Attention. The application deadline is already on 30.06.2021. It is best to register with your study coordinator as soon as possible using this form.
Watch this video to find a short introduction into the study program.
You can find even more information about the master’s program via this recording of an information event about the master profile line from Mai of 2021. The recording also starts with the previous introduction video.
Interview with Prof. Dr. Andreas Bechthold, Executive Director of the Institute of Pharmceutical Sciences of the Albert-Ludwigs-University of Freiburg, about the Master’s Program “Regulatory Affairs & Drug Development” (in German only)
Interview with Dr. Helmut Laaff , CEO – Institut für Dermatohistology, Pathology, Molecular Pathology, about the Master’s Program “Regulatory Affairs & Drug Development” (in German only)
Interview with Daniela Dietz, Head of Regulatory ad Dr. Regenold GmbH, about the Master’s Program “Regulatory Affairs & Drug Development” (in German only)
Video Testimonials of (former) Students of the Master’s Program “Regulatory Affairs & Drug Development”
The program of the lecture series at the University of Freiburg for the winter semester 2021/22 will be presented in September 2021. Further informations can be found at the GRK homepage.
The latest film from the Institute of Pharmaceutical Sciences will show you the many reasons why a Pharmaceutical Degree from Uni Freiburg is worth your time…